Anondita Medicare Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Anondita Medicare Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹145
Per ShareLot Size
1000 Shares
Minimum Investment
₹1,45,000
Issue Size
₹69.5 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35.02%
QIB Quota
49.92%
NII Quota
15.06%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Anondita Medicare Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
83.95%
Promoter Holding (Post-Issue)
61.71%
Issue Type
Book Building - SME
ISIN
INE0VTV01012
About the Company
Our Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand "COBRA". We have an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated June 04, 2025. Further, to follow sustainable production practices, our company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Noida, Uttar Pradesh.
Industry Overview
The global condom market has demonstrated robust growth through 2024-2025, reaching a valuation of approximately $14.3 billion in 2025. Market projections indicate continued expansion, with expectations of reaching $30.6 billion by 2034, representing a compound annual growth rate (CAGR) of 8.6% over the forecast period. The Indian condom market has demonstrated exceptional growth through 2024, reaching a valuation of approximately USD 245 million, representing year-on-year growth of 8.4%. Market projections indicate continued robust expansion, with expectations of reaching USD 410 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.9% over the forecast period.
Company History
Our Company was incorporated as a public limited company with the name of "Anondita Medicare Limited" under the Companies Act, 2013 vide certificate of incorporation dated March 12, 2024, issued by Registrar of Companies, Central Registration Centre, bearing CIN U22193DL2024PLC428183. Prior to this, the business of the company was run by our current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of Anondita Healthcare. Further, the entire business of Anondita Healthcare, including all assets and liabilities, was transferred to our company, Anondita Medicare Limited, vide Business Transfer Agreement dated April 01, 2024.
Products & Services
- The Company is a manufacturer of male condoms with a variety of flavors, with its flagship product marketed and sold under the brand "COBRA".
Growth Strategy
- Expanding Global Reach.
- UN Qualification and Export Launch.
- Introducing newer technology and automating manual processes.
- Launching new product lines and unique products.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets for the last reported financial year.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY25.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offering up to 47,93,000 equity shares of Rs. 10/- each ("equity shares") of Anondita Medicare Limited ("Anondita" or "AML" or the "company") for cash at a price of Rs. 145/- per equity share (the "issue price"), aggregating to Rs. 69.50 crores ("the issue"). Out of the issue, 2,70,000 equity shares aggregating to Rs. 3.92 crores will be reserved for subscription by market maker ("market maker reservation portion"). The issue less the market maker reservation portion i.e. issue of 45,23,000 equity shares of face value of Rs. 10/- each at an issue price of Rs. 145/- per equity share aggregating to Rs. 65.58 crores is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.50 % and 25.01 %, respectively of the post issue paid up equity share capital of the company.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Production capabilities.
- Experienced management team and a motivated and efficient work force.
- Cordial relations with our consumers.
- Quality assurance and control.
- The Company had negative cash flows from its operating, investing and financing activities in the past and may continue to have negative cash flows in the future. Sustained negative cash flow could impact the company growth and business.
- The company depends on its top 10 customers for a significant portion of the company revenues. The loss of a major customer or significant reduction in demand from any of its major customers may adversely affect the company business, financial condition, results of operations and prospects.
- The Company derives a significant portion of its revenue from government contracts and tenders for the supply of condoms under various public health initiatives. Participation in these tenders is subject to stringent regulatory compliance, quality standards, and other eligibility criteria. Any failures to meet the requirements enlisted in these tenders may result in the Company being debarred or disqualified from participating in future government tenders, which could have a material adverse effect on the company business, financial condition, and results of operations.
- The company had obtained secured loans amounting to Rs. 2715.37 lakhs and unsecured loans amounting to Rs. 23.73 lakhs on a consolidated basis until March 31st 2025. As such any fluctuation in interest rates or change in repayment plan may adversely affect the Company's business. Moreover, unsecured loans could be recalled by Its lenders at any time, which may be earlier than anticipated, affecting the company repayment schedule.
- Majority of assets, including both movable and immovable, have not yet been transferred under the name of the company.